Novavax Inc. Stock Rallies 6.5%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. advanced 6.5% to $9.44 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.7% to 26,151.30 and the Dow Jones Industrial Average rising 0.3% to 53,577.40.

Novavax Inc. closed 21.1% below its 52-week high of $11.97, which the company reached on February 26th.

The stock outperformed some of its peers, as Johnson & Johnson rose 0.5% to $273.14, Pfizer Inc. rose 2.1% to $28.57, and Merck & Co. Inc. rose 3.84% to $156.45.

Trading volume totaled 6.9 million, compared to the 50-day average of 4.0 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 25, 2026 16:33 ET (20:33 GMT)